Detalhe da pesquisa
1.
Cabozantinib plus Nivolumab and Ipilimumab in Renal-Cell Carcinoma.
N Engl J Med
; 388(19): 1767-1778, 2023 May 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37163623
2.
Atezolizumab plus chemotherapy versus placebo plus chemotherapy in untreated locally advanced or metastatic urothelial carcinoma (IMvigor130): final overall survival analysis results from a randomised, controlled, phase 3 study.
Lancet Oncol
; 25(1): 29-45, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38101433
3.
Atezolizumab monotherapy versus chemotherapy in untreated locally advanced or metastatic urothelial carcinoma (IMvigor130): final overall survival analysis from a randomised, controlled, phase 3 study.
Lancet Oncol
; 25(1): 46-61, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38101431
4.
Atezolizumab with or without chemotherapy in metastatic urothelial cancer (IMvigor130): a multicentre, randomised, placebo-controlled phase 3 trial.
Lancet
; 395(10236): 1547-1557, 2020 05 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-32416780
5.
Nivolumab versus everolimus in patients with advanced renal cell carcinoma: Updated results with long-term follow-up of the randomized, open-label, phase 3 CheckMate 025 trial.
Cancer
; 126(18): 4156-4167, 2020 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32673417
6.
Use of Immunotherapy in Patients With Cancer During the COVID-19 Pandemic.
Oncology (Williston Park)
; 34(9): 370-376, 2020 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32965669
7.
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma.
N Engl J Med
; 373(19): 1803-13, 2015 Nov 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-26406148
8.
First Brazilian Consensus of Advanced Prostate Cancer: Recommendations for Clinical Practice.
Int Braz J Urol
; 43(3): 407-415, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28199075
9.
Single nucleotide polymorphisms and risk of recurrence of renal-cell carcinoma: a cohort study.
Lancet Oncol
; 14(1): 81-7, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23219378
10.
Latin American Consensus for the Evaluation and Treatment of Patients With Metastatic/Locally Advanced Urothelial Carcinoma.
JCO Glob Oncol
; 10: e2300244, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38271646
11.
Advanced renal cell carcinoma management: the Latin American Cooperative Oncology Group (LACOG) and the Latin American Renal Cancer Group (LARCG) consensus update.
J Cancer Res Clin Oncol
; 150(4): 183, 2024 Apr 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38594593
12.
Multicenter Database of Patients with Germ-Cell Tumors: A Latin American Cooperative Oncology Group Registry (LACOG 0515).
Clin Genitourin Cancer
; 21(3): e104-e113, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36509612
13.
Treatment Patterns Among Patients With Advanced Prostate Cancer in Brazil: An Analysis of a Private Healthcare System Database.
World J Oncol
; 13(6): 350-358, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36660210
14.
Association of androgen deprivation therapy with cardiovascular death in patients with prostate cancer: a meta-analysis of randomized trials.
JAMA
; 306(21): 2359-66, 2011 Dec 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-22147380
15.
Erdafitinib treatment in Brazilian patients with metastatic urothelial carcinoma (mUC): real-world evidence from an Expanded Access Program.
Ther Adv Med Oncol
; 13: 17588359211015499, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34046088
16.
A phase 2 randomized clinical trial of abiraterone plus ADT, apalutamide, or abiraterone and apalutamide in patients with advanced prostate cancer with non-castrate testosterone levels (LACOG 0415).
Eur J Cancer
; 158: 63-71, 2021 Oct 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-34655838
17.
Consensus for Treatment of Metastatic Castration-Sensitive Prostate Cancer: Report From the First Global Prostate Cancer Consensus Conference for Developing Countries (PCCCDC).
JCO Glob Oncol
; 7: 550-558, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33856896
18.
Consensus on Treatment and Follow-Up for Biochemical Recurrence in Castration-Sensitive Prostate Cancer: A Report From the First Global Prostate Cancer Consensus Conference for Developing Countries.
JCO Glob Oncol
; 7: 538-544, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33856897
19.
Risk of bleeding with vascular endothelial growth factor receptor tyrosine-kinase inhibitors sunitinib and sorafenib: a systematic review and meta-analysis of clinical trials.
Lancet Oncol
; 10(10): 967-74, 2009 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-19767240
20.
First-line Treatment of Metastatic Renal Cell Carcinoma in the Immuno-oncology Era: Systematic Review and Network Meta-analysis.
Clin Genitourin Cancer
; 18(4): 244-251.e4, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32303427